Your browser doesn't support javascript.
loading
The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin.
Cuyàs, Elisabet; Buxó, Maria; Ferri Iglesias, Maria José; Verdura, Sara; Pernas, Sonia; Dorca, Joan; Álvarez, Isabel; Martínez, Susana; Pérez-Garcia, Jose Manuel; Batista-López, Norberto; Rodríguez-Sánchez, César A; Amillano, Kepa; Domínguez, Severina; Luque, Maria; Morilla, Idoia; Stradella, Agostina; Viñas, Gemma; Cortés, Javier; Joven, Jorge; Brunet, Joan; López-Bonet, Eugeni; Garcia, Margarita; Saidani, Samiha; Queralt Moles, Xavier; Martin-Castillo, Begoña; Menendez, Javier A.
Afiliación
  • Cuyàs E; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.
  • Buxó M; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
  • Ferri Iglesias MJ; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
  • Verdura S; Laboratori Clínic Territorial, Parque Hospitalario Martí i Julià, Salt, Spain.
  • Pernas S; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.
  • Dorca J; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
  • Álvarez I; Breast Unit, Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Martínez S; Medical Oncology, Catalan Institute of Oncology, Girona, Spain.
  • Pérez-Garcia JM; Medical Oncology Service, Hospital Universitario Donostia, Donostia-San Sebastián, Spain.
  • Batista-López N; Biodonostia Health Research Institute, Donostia-San Sebastián, Spain.
  • Rodríguez-Sánchez CA; Medical Oncology Department, Hospital de Mataró, Mataró, Barcelona, Spain.
  • Amillano K; Hospital Quirón, IOB Institute of Oncology, Barcelona, Spain.
  • Domínguez S; Medical Oncology Service, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Spain.
  • Luque M; Medical Oncology Service, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Morilla I; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
  • Stradella A; Medical Oncology, Hospital Universitari Sant Joan, Reus, Spain.
  • Viñas G; Medical Oncology Service, Hospital Universitario Araba, Vitoria-Gasteiz, Spain.
  • Cortés J; Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Joven J; Breast Unit, Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Brunet J; Breast Unit, Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • López-Bonet E; Medical Oncology, Catalan Institute of Oncology, Girona, Spain.
  • Garcia M; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain.
  • Saidani S; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, IISPV, Rovira i Virgili University, Reus, Spain.
  • Queralt Moles X; Medical Oncology, Catalan Institute of Oncology, Girona, Spain.
  • Martin-Castillo B; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Menendez JA; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
Front Oncol ; 9: 193, 2019.
Article en En | MEDLINE | ID: mdl-30984619
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2019 Tipo del documento: Article